Developer docs
API playgroundTry for free, no card

Search company profiles

Genomatica

Full company profile

uuid000098r

Namestring
Genomatica
Legal namestring
Genomatica, Inc.
Websiteurl
genomatica.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Genomatica (operating commercially as "Geno") is a San Diego-based industrial biotechnology company founded in 2000 that develops and licenses proprietary fermentation-based processes to produce widely-used chemicals from plant-based sugars instead of fossil fuels. Its technology platform encompasses proprietary biocatalysts and metabolic engineering capabilities enabling single-step fermentation to produce butanediol (BDO), butylene glycol, caprolactam and HMD (nylon-6 and nylon-6,6 precursors), and long-chain chemicals, protected by over 1,500 active patents and applications. Major product lines include GENO Bio-BDO (1,4-butanediol, branded as QIRA by Qore), Brontide natural butylene glycol for personal care, plant-based nylon-6 and nylon-6,6 for textiles and engineering plastics, and Avela (R)-1,3-Butanediol for ketogenic functional foods.

The company operates a capital-light, technology-licensing business model: it does not own commercial-scale manufacturing but rather licenses its process technology to global manufacturing partners — including Qore (Cargill-HELM JV), Novamont, Hyosung, Aquafil, Asahi Kasei, and Covestro — who fund, build, and operate production facilities. Brontide is sold through exclusive regional distributors (Azelis in Europe, Glenn/Azelis Americas in North America, Daicel in Asia-Pacific) to over 250 personal care formulators. Revenue derives from upfront licensing fees, royalties on licensed production, and direct product sales of Brontide, supplemented by strategic equity investments from consumer brands such as Lululemon, Unilever, Kao, and L'Oréal that provide both capital and offtake validation. Geno's technology enables up to 90% lower carbon emissions versus fossil-based equivalents and has been independently validated through three EPA Green Chemistry Challenge Awards, three consecutive ICIS Innovation Awards, TIME Best Invention 2019, and ISCC+/BioPreferred certifications on partner-deployed outputs.

Short descriptiontext

Genomatica (Geno) is a San Diego-based industrial biotech company founded in 2000 that licenses proprietary fermentation technology to global manufacturers, enabling production of plant-based BDO, butylene glycol, nylon-6/6,6, and long-chain chemicals as drop-in replacements for fossil-fuel-derived inputs serving apparel, personal care, and chemicals customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
industrial biomanufacturing, sustainable chemicals, fermentation technology, bio-based materials, biotechnology licensing
Industry4 codes
PRIMARYIMAEAOAA
Biodegradable Polymers & Resins (PLA, PHA, PBS, PBAT)
SECONDARYEUAAAIAC
Bio-based Polymers & Bioplastics (e.g., PLA, PHA, bio-PE/PP/PET, PBS)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYEUAAAIAA
Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYIMAEAOAB
Biodegradable Packaging Materials (films, trays, foams)
NAICS code2 codes
  • Plastics Material and Resin Manufacturing325211
  • Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing3252
SIC code2 codes
  • Plastic Materials, Synth Resins & Nonvulcan Elastomers2821
  • Industrial Organic Chemicals2860
Product category
Industrial Biotechnology / Sustainable Chemicals
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Technology Licensing
TypeLicensing Royalties
Description

Geno licenses its proprietary biomanufacturing process technology to global manufacturers. Licensees include Qore (Cargill-HELM JV), Novamont, Hyosung, and others. Receives license fees and royalties in exchange for technology packages, process design packages, and technology services.

genomatica.com
2Equity Investment from Partners
TypeLicensing Royalties
Description

Large consumer brands invest equity in Geno for access to sustainable materials technology. Lululemon made its first-ever equity investment in Geno. This provides capital while establishing strategic partnership relationships.

genomatica.com
3Product Sales (Brontide)
TypeHardware Sales
Description

Brontide butylene glycol sold through distribution partners (Azelis, Glenn, Daicel) to personal care formulators. Commercial production achieved with over 600 tons shipped, over 250 formulators received samples.

genomatica.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
Pricing details1 tier
1No public pricing available
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing not publicly disclosed; quote-based / negotiated for technology licensing arrangements.

einpresswire.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Geno BDO
Description

Bio-based 1,4-butanediol produced through proprietary fermentation technology using plant-based sugars

genomatica.com
+2 more records
Core offering1 text field

Genomatica develops, licenses, and supplies proprietary biomanufacturing technology that uses fermentation to convert plant-based sugars into widely used chemicals and materials as fossil-fuel-free alternatives to petrochemical equivalents. Its commercial offerings include GENO Bio-BDO (1,4-butanediol), Brontide butylene glycol, plant-based nylon precursors, and Avela (R)-1,3-butanediol, sold to industrial and consumer-goods manufacturers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • Up to 90% lower carbon emissions for Bio-BDO compared to coal-based alternatives
+7 more records
Product overview1 text field

Genomatica (operating as Geno) is a biotechnology company that develops and licenses industrial biomanufacturing technologies to produce widely-used chemicals and materials from plant-based or waste feedstocks instead of fossil fuels. The company's core technology portfolio includes three major product platforms: the C4 platform (producing GENO™ Bio-BDO and Brontide™ butylene glycol), the C6 platform (producing plant-based nylon-6 via caprolactam and nylon-6,6 via HMD), and a long-chain chemicals platform acquired from REG Life Sciences. Genomatica licenses its proprietary biocatalyst and process technologies to global manufacturing partners rather than operating its own production facilities. The technology enables up to 90% lower carbon emissions compared to fossil-based alternatives while maintaining equivalent performance.

Product and service4 records
1GENO Bio-BDO
CategoryBio-based commodity chemical
Description

Bio-based 1,4-butanediol (BDO) produced from plant-based sugars via fermentation; used as a drop-in replacement for petrochemical BDO in downstream polymer, spandex, and chemical applications for global chemical manufacturers and brand owners.

2Brontide butylene glycol
CategorySpecialty personal-care ingredient
Description

Natural-origin (sugarcane-derived) 1,3-butylene glycol used as a sustainable, petrochemical-free ingredient in personal care and cosmetics formulations, distributed via partners such as Azelis, Glenn, and Daicel.

3Plant-Based Nylon
CategoryBio-based polymer intermediate
Description

Bio-based nylon-6 and nylon-6,6 precursors produced via fermentation; supplied into apparel and textile applications (e.g., partnership with Hyosung and brand adoption by lululemon and Unilever) as a sustainable alternative to petrochemical nylon.

4Avela (R)-1,3-Butanediol
CategorySpecialty nutrition ingredient
Description

Nature-derived (R)-1,3-Butanediol produced from plant-based sugars via fermentation; sold to functional food, beverage, and nutrition product developers for ketogenic and calorie-reduction applications.

Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
1Sojitz Corporation
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-10
Description

Strategic partnership to accelerate commercialization of world's first plant-based nylon-6. Sojitz made strategic financial investment and contributes commercial/business expertise. Aligns with Sojitz's 'Sustainability Challenge' for decarbonization and sustainable growth.

worldbiomarketinsights.com
Strategic tierFlagshipTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2025-10-07
Description

Geno licensed GENO Bio-BDO technology to Qore, joint venture between Cargill and HELM. $300M facility in Eddyville, Iowa is world's largest Geno Bio-BDO plant. Produces BDO under brand QIRA. Combined capacity over 100,000 tons per year.

3Hyosung
Strategic tierFlagshipTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2024-05-01
Description

$1 billion investment in building Geno-powered BDO plants in Vietnam. World's first fully integrated manufacturing site for bio-based spandex from renewable raw material to fiber. Annual capacity of 50,000 tons with aim to expand to 200,000 tons/year.

genomatica.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-29
Description

Joined Unilever-Geno venture as founding member to strengthen supply chain resiliency for $652B home and personal care markets. Kao's 130+ years of expertise deepens global reach. Supports Kao's goal to reduce CO2 emissions to zero by 2040 and become carbon negative by 2050.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-07-20
Description

Longtime collaboration with Aquafil to produce plant-based nylon-6. Successfully completed first demonstration scale production runs. Aquafil converts Geno's bio-based precursor to commercial-quality bio-nylon-6 yarns, films, and engineered plastics at Slovenia facility.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2022-06-16
Description

$120M+ joint venture to scale and commercialize plant-based alternatives to palm oil and fossil fuels for cleansing ingredients. Unilever's largest collaboration in biotechnology alternatives to palm oil. Targets combined $625B home and personal care markets with potential for 50% carbon footprint reduction.

7Asahi Kasei
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-03-15
Description

Partnership to commercialize renewably-sourced nylon 6,6 made from Geno's bio-based HMD (hexamethylenediamine). Asahi Kasei targets first-to-market with sustainable nylon 6,6 for automotive and electronics industries, supporting goal to be carbon neutral by 2050.

genomatica.com
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2021-08-18
Description

Multi-year collaboration with lululemon's first-ever equity investment in a sustainable materials company. Geno's largest retail industry partnership. Goal to replace conventional nylon with plant-based alternatives in lululemon products, impacting over half of synthetic materials in their supply chain, supporting 2030 sustainability goals.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2020-05-12
Description

Exclusive distributor of Brontide natural butylene glycol in the United States. Glenn brings 16 technical account managers dedicated to personal care industry, application lab capabilities with e-Lab and iChat digital tools.

10Daicel
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2019-10-30
Description

Exclusive distributor of Brontide butylene glycol in Asia-Pacific region. Anticipated purchases to grow to thousands of tons per year. Daicel has established and respected presence in Asian cosmetics market.

genomatica.com
11Covestro
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-03-27
Description

Partnership to research and develop high-performance materials from renewable feedstocks. Successfully produced significant volumes of plant-based HMDA for coatings and nylon-6,6. Covestro has secured option to license GENO HMD process technology.

genomatica.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Marketing and distribution partner for Brontide in Europe. Azelis has EcoVadis Gold rating placing it in top 1% of distributors worldwide for corporate social responsibility.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Longtime partner producing Brontide at fermentation-based production plant in Italy. First commercial plant for bio-based BDO with 30,000 ton annual capacity, reducing greenhouse gas emissions by 50% vs petroleum-based production.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Third global company to invest in Geno-led venture for sustainably sourced ingredients. Supports L'Oréal's sustainability commitments and ingredient sourcing goals.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Industrial biotechnology company producing bio-based chemicals and ingredients via fermentation from renewable feedstocks. Directly comparable to Geno in business model of licensing/selling bio-based molecules to consumer goods and personal care markets (e.g., squalane, sweeteners).

TypeDirect peer
Description

Synthetic biology platform engineering microorganisms for bio-based chemical and ingredient production. Existing Geno partner (Geno strengthened Ginkgo partnership with $90M Series B) and competes for similar bio-manufacturing licensing opportunities with consumer goods and chemical majors.

TypeDirect peer
Description

Carbon recycling company using gas fermentation to produce bio-based ethanol and chemicals from industrial off-gases. Comparable to Geno as a biotechnology licensing company targeting sustainable chemical production for major brands.

TypeDirect peer
Description

World's largest PLA bioplastic manufacturer, producing bio-based polymers from plant sugars for packaging and consumer goods applications. Directly comparable to Geno's bio-based polymer/resin manufacturing and licensing approach.

5Braskem
TypeBroad incumbent
Description

Major petrochemical producer that has commercialized bio-based polyethylene (I'm green) from sugarcane. Competes with Geno in bio-based polyolefins and serves similar consumer goods customers seeking sustainable materials.

TypeBroad incumbent
Description

Global chemical major with growing biotechnological and bio-based materials portfolio including compostable bioplastics (ecovio) and bio-based intermediates. Represents the established incumbent Geno competes against and partners with in the renewable chemicals space.

TypeBroad incumbent
Description

One of the world's largest plastics, chemicals, and refining companies with active investments in circular and bio-based polymers. Competes broadly with Geno in the sustainable materials market and is exploring licensing-style partnerships for advanced recycling and bio-based feedstocks.

TypeDirect peer
Description

Bioplastic company producing PHA (polyhydroxyalkanoate) biodegradable polymers from renewable feedstocks. Direct comparable to Geno in bio-based and biodegradable polymer production, particularly for packaging applications.

9Cathay Industrial Biotech
TypeDirect peer
Description

Chinese bio-based chemicals company producing bio-based polyamide (nylon-56), bio-based pentanediol, and bio-based long-chain diacids. Directly comparable to Geno's bio-based nylon and C6 platform products.

TypeOthers
Description

Global agricultural commodity processor and JV partner with Geno through the Qore Bio-BDO joint venture with HELM. Comparable as an enabling ecosystem participant supplying plant-sugar feedstocks and operating licensed Geno production capacity in Iowa.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors19 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Genomatica

Industrial Biotechnology / Sustainable Chemicalsgenomatica.com

Genomatica (Geno) is a San Diego-based industrial biotech company founded in 2000 that licenses proprietary fermentation technology to global manufacturers, enabling production of plant-based BDO, butylene glycol, nylon-6/6,6, and long-chain chemicals as drop-in replacements for fossil-fuel-derived inputs serving apparel, personal care, and chemicals customers.

What Genomatica does

Genomatica (operating commercially as "Geno") is a San Diego-based industrial biotechnology company founded in 2000 that develops and licenses proprietary fermentation-based processes to produce widely-used chemicals from plant-based sugars instead of fossil fuels. Its technology platform encompasses proprietary biocatalysts and metabolic engineering capabilities enabling single-step fermentation to produce butanediol (BDO), butylene glycol, caprolactam and HMD (nylon-6 and nylon-6,6 precursors), and long-chain chemicals, protected by over 1,500 active patents and applications. Major product lines include GENO Bio-BDO (1,4-butanediol, branded as QIRA by Qore), Brontide natural butylene glycol for personal care, plant-based nylon-6 and nylon-6,6 for textiles and engineering plastics, and Avela (R)-1,3-Butanediol for ketogenic functional foods.

The company operates a capital-light, technology-licensing business model: it does not own commercial-scale manufacturing but rather licenses its process technology to global manufacturing partners — including Qore (Cargill-HELM JV), Novamont, Hyosung, Aquafil, Asahi Kasei, and Covestro — who fund, build, and operate production facilities. Brontide is sold through exclusive regional distributors (Azelis in Europe, Glenn/Azelis Americas in North America, Daicel in Asia-Pacific) to over 250 personal care formulators. Revenue derives from upfront licensing fees, royalties on licensed production, and direct product sales of Brontide, supplemented by strategic equity investments from consumer brands such as Lululemon, Unilever, Kao, and L'Oréal that provide both capital and offtake validation. Geno's technology enables up to 90% lower carbon emissions versus fossil-based equivalents and has been independently validated through three EPA Green Chemistry Challenge Awards, three consecutive ICIS Innovation Awards, TIME Best Invention 2019, and ISCC+/BioPreferred certifications on partner-deployed outputs.

Genomatica firmographics

Firmographics
Name
Genomatica
Legal name
Genomatica, Inc.
Website
https://genomatica.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
101–250 employees
Short description
Genomatica (Geno) is a San Diego-based industrial biotech company founded in 2000 that licenses proprietary fermentation technology to global manufacturers, enabling production of plant-based BDO, butylene glycol, nylon-6/6,6, and long-chain chemicals as drop-in replacements for fossil-fuel-derived inputs serving apparel, personal care, and chemicals customers.
Ownership category
akta.pro rank

Genomatica industry classification

Industry
Product category
Industrial Biotechnology / Sustainable Chemicals
NAICS
Plastics Material and Resin Manufacturing (325211), Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing (3252)
SIC
Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821), Industrial Organic Chemicals (2860)
akta.pro industry
PRIMARYIMAEAOAA
Biodegradable Polymers & Resins (PLA, PHA, PBS, PBAT)
SECONDARYEUAAAIAC
Bio-based Polymers & Bioplastics (e.g., PLA, PHA, bio-PE/PP/PET, PBS)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYEUAAAIAA
Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYIMAEAOAB
Biodegradable Packaging Materials (films, trays, foams)

Keywords

  • Industrial biomanufacturing
  • Sustainable chemicals
  • Fermentation technology
  • Bio-based materials
  • Biotechnology licensing

Where Genomatica is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Genomatica business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Technology Licensing: Geno licenses its proprietary biomanufacturing process technology to global manufacturers. Licensees include Qore (Cargill-HELM JV), Novamont, Hyosung, and others. Receives license fees and royalties in exchange for technology packages, process design packages, and technology services.
  2. Equity Investment from Partners: Large consumer brands invest equity in Geno for access to sustainable materials technology. Lululemon made its first-ever equity investment in Geno. This provides capital while establishing strategic partnership relationships.
  3. Product Sales (Brontide): Brontide butylene glycol sold through distribution partners (Azelis, Glenn, Daicel) to personal care formulators. Commercial production achieved with over 600 tons shipped, over 250 formulators received samples.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractNo public pricing available

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Genomatica product offering

Product offering

Core offering

Genomatica develops, licenses, and supplies proprietary biomanufacturing technology that uses fermentation to convert plant-based sugars into widely used chemicals and materials as fossil-fuel-free alternatives to petrochemical equivalents. Its commercial offerings include GENO Bio-BDO (1,4-butanediol), Brontide butylene glycol, plant-based nylon precursors, and Avela (R)-1,3-butanediol, sold to industrial and consumer-goods manufacturers.

Product overview

Genomatica (operating as Geno) is a biotechnology company that develops and licenses industrial biomanufacturing technologies to produce widely-used chemicals and materials from plant-based or waste feedstocks instead of fossil fuels. The company's core technology portfolio includes three major product platforms: the C4 platform (producing GENO™ Bio-BDO and Brontide™ butylene glycol), the C6 platform (producing plant-based nylon-6 via caprolactam and nylon-6,6 via HMD), and a long-chain chemicals platform acquired from REG Life Sciences. Genomatica licenses its proprietary biocatalyst and process technologies to global manufacturing partners rather than operating its own production facilities. The technology enables up to 90% lower carbon emissions compared to fossil-based alternatives while maintaining equivalent performance.

Differentiator

Problem solved

Functional benefit

Brands

  • Geno BDO: Bio-based 1,4-butanediol produced through proprietary fermentation technology using plant-based sugars
  • Brontide
  • Avela

Products and services

  • GENO Bio-BDO Bio-based 1,4-butanediol (BDO) produced from plant-based sugars via fermentation; used as a drop-in replacement for petrochemical BDO in downstream polymer, spandex, and chemical applications for global chemical manufacturers and brand owners.
  • Brontide butylene glycol Natural-origin (sugarcane-derived) 1,3-butylene glycol used as a sustainable, petrochemical-free ingredient in personal care and cosmetics formulations, distributed via partners such as Azelis, Glenn, and Daicel.
  • Plant-Based Nylon Bio-based nylon-6 and nylon-6,6 precursors produced via fermentation; supplied into apparel and textile applications (e.g., partnership with Hyosung and brand adoption by lululemon and Unilever) as a sustainable alternative to petrochemical nylon.
  • Avela (R)-1,3-Butanediol Nature-derived (R)-1,3-Butanediol produced from plant-based sugars via fermentation; sold to functional food, beverage, and nutrition product developers for ketogenic and calorie-reduction applications.

Quantifiable outcome

  • Up to 90% lower carbon emissions for Bio-BDO compared to coal-based alternatives
  • +7 more outcomes

Companies that use Genomatica

Customer profile

Named customers12 records

Segments5 records

Ideal customer profiles4 records

Genomatica technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Genomatica partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core and flagship.

  • Sojitz CorporationcoreStrategic or Co-development Partner · 10 October 2025Strategic partnership to accelerate commercialization of world's first plant-based nylon-6. Sojitz made strategic financial investment and contributes commercial/business expertise. Aligns with Sojitz's 'Sustainability Challenge' for decarbonization and sustainable growth.
  • Qore (Cargill-HELM Joint Venture)flagshipOEM/ Whitelabel/ Licensing Partner · 7 October 2025Geno licensed GENO Bio-BDO technology to Qore, joint venture between Cargill and HELM. $300M facility in Eddyville, Iowa is world's largest Geno Bio-BDO plant. Produces BDO under brand QIRA. Combined capacity over 100,000 tons per year.
  • HyosungflagshipOEM/ Whitelabel/ Licensing Partner · 1 May 2024$1 billion investment in building Geno-powered BDO plants in Vietnam. World's first fully integrated manufacturing site for bio-based spandex from renewable raw material to fiber. Annual capacity of 50,000 tons with aim to expand to 200,000 tons/year.
  • KaocoreStrategic or Co-development Partner · 29 September 2022Joined Unilever-Geno venture as founding member to strengthen supply chain resiliency for $652B home and personal care markets. Kao's 130+ years of expertise deepens global reach. Supports Kao's goal to reduce CO2 emissions to zero by 2040 and become carbon negative by 2050.
  • AquafilcoreStrategic or Co-development Partner · 20 July 2022Longtime collaboration with Aquafil to produce plant-based nylon-6. Successfully completed first demonstration scale production runs. Aquafil converts Geno's bio-based precursor to commercial-quality bio-nylon-6 yarns, films, and engineered plastics at Slovenia facility.
  • UnileverflagshipStrategic or Co-development Partner · 16 June 2022$120M+ joint venture to scale and commercialize plant-based alternatives to palm oil and fossil fuels for cleansing ingredients. Unilever's largest collaboration in biotechnology alternatives to palm oil. Targets combined $625B home and personal care markets with potential for 50% carbon footprint reduction.
  • Asahi KaseicoreStrategic or Co-development Partner · 15 March 2022Partnership to commercialize renewably-sourced nylon 6,6 made from Geno's bio-based HMD (hexamethylenediamine). Asahi Kasei targets first-to-market with sustainable nylon 6,6 for automotive and electronics industries, supporting goal to be carbon neutral by 2050.
  • lululemonflagshipStrategic or Co-development Partner · 18 August 2021Multi-year collaboration with lululemon's first-ever equity investment in a sustainable materials company. Geno's largest retail industry partnership. Goal to replace conventional nylon with plant-based alternatives in lululemon products, impacting over half of synthetic materials in their supply chain, supporting 2030 sustainability goals.
  • Glenn (Azelis Americas)coreChannel Partner/ Reseller/ Distributor · 12 May 2020Exclusive distributor of Brontide natural butylene glycol in the United States. Glenn brings 16 technical account managers dedicated to personal care industry, application lab capabilities with e-Lab and iChat digital tools.
  • DaicelcoreChannel Partner/ Reseller/ Distributor · 30 October 2019Exclusive distributor of Brontide butylene glycol in Asia-Pacific region. Anticipated purchases to grow to thousands of tons per year. Daicel has established and respected presence in Asian cosmetics market.
  • CovestrocoreStrategic or Co-development Partner · 27 March 2019Partnership to research and develop high-performance materials from renewable feedstocks. Successfully produced significant volumes of plant-based HMDA for coatings and nylon-6,6. Covestro has secured option to license GENO HMD process technology.
  • AzeliscoreChannel Partner/ Reseller/ DistributorMarketing and distribution partner for Brontide in Europe. Azelis has EcoVadis Gold rating placing it in top 1% of distributors worldwide for corporate social responsibility.
  • NovamontcoreOEM/ Whitelabel/ Licensing PartnerLongtime partner producing Brontide at fermentation-based production plant in Italy. First commercial plant for bio-based BDO with 30,000 ton annual capacity, reducing greenhouse gas emissions by 50% vs petroleum-based production.
  • L'OréalcoreStrategic or Co-development PartnerThird global company to invest in Geno-led venture for sustainably sourced ingredients. Supports L'Oréal's sustainability commitments and ingredient sourcing goals.

Scale indicators16 records

Recent moves9 records

Expansion highlights6 records

Genomatica competitors and assessment

Company assessment

Direct peers

  • Amyris: Industrial biotechnology company producing bio-based chemicals and ingredients via fermentation from renewable feedstocks. Directly comparable to Geno in business model of licensing/selling bio-based molecules to consumer goods and personal care markets (e.g., squalane, sweeteners).
  • Ginkgo Bioworks: Synthetic biology platform engineering microorganisms for bio-based chemical and ingredient production. Existing Geno partner (Geno strengthened Ginkgo partnership with $90M Series B) and competes for similar bio-manufacturing licensing opportunities with consumer goods and chemical majors.
  • LanzaTech: Carbon recycling company using gas fermentation to produce bio-based ethanol and chemicals from industrial off-gases. Comparable to Geno as a biotechnology licensing company targeting sustainable chemical production for major brands.
  • NatureWorks: World's largest PLA bioplastic manufacturer, producing bio-based polymers from plant sugars for packaging and consumer goods applications. Directly comparable to Geno's bio-based polymer/resin manufacturing and licensing approach.
  • Danimer Scientific: Bioplastic company producing PHA (polyhydroxyalkanoate) biodegradable polymers from renewable feedstocks. Direct comparable to Geno in bio-based and biodegradable polymer production, particularly for packaging applications.
  • Cathay Industrial Biotech: Chinese bio-based chemicals company producing bio-based polyamide (nylon-56), bio-based pentanediol, and bio-based long-chain diacids. Directly comparable to Geno's bio-based nylon and C6 platform products.

Broad incumbents

  • Braskem: Major petrochemical producer that has commercialized bio-based polyethylene (I'm green) from sugarcane. Competes with Geno in bio-based polyolefins and serves similar consumer goods customers seeking sustainable materials.
  • BASF: Global chemical major with growing biotechnological and bio-based materials portfolio including compostable bioplastics (ecovio) and bio-based intermediates. Represents the established incumbent Geno competes against and partners with in the renewable chemicals space.
  • LyondellBasell: One of the world's largest plastics, chemicals, and refining companies with active investments in circular and bio-based polymers. Competes broadly with Geno in the sustainable materials market and is exploring licensing-style partnerships for advanced recycling and bio-based feedstocks.

Others

  • Cargill: Global agricultural commodity processor and JV partner with Geno through the Qore Bio-BDO joint venture with HELM. Comparable as an enabling ecosystem participant supplying plant-sugar feedstocks and operating licensed Geno production capacity in Iowa.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks4 records

Key highlights6 records

Customer concentration

Genomatica social profiles

Digital presence

Genomatica compliance and trust

Trust signal

Compliance4 records

Genomatica financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Genomatica leadership team

Management profile

Number of profiles

Profiles4 records

Genomatica funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors19 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Genomatica M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genomatica

What does Genomatica do?

Genomatica develops, licenses, and supplies proprietary biomanufacturing technology that uses fermentation to convert plant-based sugars into widely used chemicals and materials as fossil-fuel-free alternatives to petrochemical equivalents. Its commercial offerings include GENO Bio-BDO (1,4-butanediol), Brontide butylene glycol, plant-based nylon precursors, and Avela (R)-1,3-butanediol, sold to industrial and consumer-goods manufacturers.

Is Genomatica a public or private company?

Genomatica is a private company. It is classified as venture growth investor backed and is currently operating.

When was Genomatica founded?

Genomatica was founded in 2000. It employs 101 to 250 people.

Where is Genomatica based?

Genomatica is headquartered in San Diego, United States, in the North America region.

How does Genomatica make money?

Three revenue lines are on record. Technology Licensing is the primary driver. The others are equity Investment from Partners and product Sales (Brontide).

Who are Genomatica's main competitors?

Direct peers on record are Amyris, Ginkgo Bioworks, LanzaTech, NatureWorks, Danimer Scientific and Cathay Industrial Biotech. Broad incumbents are Braskem, BASF and LyondellBasell. Cargill is listed as an others.

Does Genomatica have an API?

No public API is recorded for Genomatica.

What industry is Genomatica in?

Genomatica's product category is Industrial Biotechnology / Sustainable Chemicals. Its primary akta.pro industry code is IMAEAOAA, Biodegradable Polymers & Resins (PLA, PHA, PBS, PBAT), with a secondary code of EUAAAIAC, Bio-based Polymers & Bioplastics (e.g., PLA, PHA, bio-PE/PP/PET, PBS). Its NAICS code is 325211 and its SIC code is 2821.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
European BiotechnologyCopenhagen-based Again acquires US Geno to connect AI-driven discovery with industrial biomanufacturingCopenhagen-based Again acquired Genomatica to integrate AI-driven pathway design with industrial bioprocess scale-up. The deal aims to close the gap between computational discovery and commercial production, with financial terms undisclosed. Again plans to integrate Geno's data into its computational systems to improve predictive models.YahooAmid Genomatica and Asahi Kasei Scaling Microbial Fermentation for Bio-Nylon 6,6, New Report Analyzes Global Bio-Adipic Acid ExpansionA new market report forecasts the global bio-adipic acid market to grow from USD 153.1 million in 2025 to USD 506 million by 2035, driven by microbial fermentation advancements and sustainability regulations. Key industry players including Invista, Ascend Performance Materials, Genomatica, Asahi Kasei Corporation, and Radici Group are accelerating the transition toward bio-based chemical intermediates through certifications, expansions, and licensing agreements.SiliconANGLEGoogle launches five new Pixel devices, array of Gemini Intelligence featuresDenmark-based biotech company Again announced the acquisition of Genomatica Inc. to combine its modular bioreactor technology with Geno’s AI-driven biomolecule design platform. The transaction aims to accelerate the commercialization of eco-friendly chemicals by leveraging data and patents to reduce carbon emissions, with a combined estimated capacity to divert up to 85 million tons of CO2 annually.ArcticstartupDanish startup Again acquires Genomatica, bringing together AI and biomanufacturingCopenhagen-based biomanufacturing company Again has acquired San Diego-based industrial biotechnology firm Genomatica, integrating Geno's computational biology and bioprocess engineering capabilities with Again's AI-driven scale-up platform. Financial terms were not disclosed. Geno holds over 1,100 patents and two decades of proprietary data. Again operates in Copenhagen, Munich and Houston.The TennesseanAgain Acquires Geno, Combining Bio-Manufacturing Scale with Advanced AI Discovery and DesignAgain announced its acquisition of Genomatica (Geno), combining its biomanufacturing scale-up capabilities with Geno's AI discovery and design platform. The deal integrates Geno's computational tools and data into Again's engines, aiming to compress timelines from pathway design to industrial execution. Terms were not disclosed.Tech.euAgain acquires Geno to combine AI-driven discovery with industrial biomanufacturingAgain acquired industrial biotechnology company Genomatica, combining their bioprocess engineering and AI-driven discovery capabilities. Financial terms were not disclosed. The combined company plans to integrate Geno's AI platform to shorten development cycles and operate through licensing and co-development models.EIN PresswireAgain Acquires Geno, Combining Bio-Manufacturing Scale with Advanced AI Discovery and DesignAgain announced its acquisition of Genomatica (Geno), combining its scale-up platform with Geno's AI discovery and design capabilities. The deal integrates Geno's full-stack simulation and patent portfolio into Again's computational engines, aiming to compress timelines from pathway design to industrial execution. Terms were not disclosed.Fact.MRBio Alcohol Market, Global Market Analysis ReportFact.MR's bio alcohol market report shows the industry crossed USD 11.6 billion in 2025 and is projected to reach USD 12.3 billion in 2026, growing to USD 24.4 billion by 2036 at a 7.1% CAGR. Growth is driven by fuel blending mandates and renewable chemical substitution, with Brazil recording the fastest growth at 7.6% CAGR due to its E30 adoption and established ethanol infrastructure. Key companies including Cargill Inc., Genomatica Inc., and Raízen S.A. compete through feedstock access, alcohol purity, and technology depth across fuel, chemical, and pharmaceutical applications.UC San Diego TodayThe Engineer Who Taught Cells to BehaveBernhard Palsson, a bioengineering professor at UC San Diego, has built a career developing computational models that make cellular behavior predictable and programmable, pioneering genome-scale metabolic models starting with E. coli in 2000 and extending to human metabolism. He has founded multiple biotechnology companies including Aastrom Biosciences (now Vericel Corporation), Genomatica, GT Life Sciences, and Sinopia Biosciences, and led the Novo Nordisk Foundation Center for Biosustainability in Denmark from 2010 to 2022, which spun out over 35 companies. His current work includes a $4.1 million DARPA subcontract to build a whole-cell "digital twin" model of E. coli to predict antibiotic resistance and inform patient care.EIN PresswireNylon 6 Market Growth Overview, Facts & Figures, Segmentation, Future Trends and Historical Analysis By 2033The global Nylon 6 market is projected to grow from USD 17.34 billion in 2025 to USD 26.95 billion by 2032, with a compound annual growth rate (CAGR) of 6.5%, driven by increasing demand from automotive, textile, and electrical & electronics industries. Key growth factors include the shift toward lightweight materials in vehicle manufacturing and rising adoption of engineering plastics, while challenges include fluctuating raw material prices and stricter environmental regulations. Recent developments include a partnership between Genomatica and Sojitz to scale plant-based Nylon-6, and a joint initiative by BASF and Inditex to introduce Loopamid, a circular nylon made from textile waste.